OncoVista Innovative Therapies (OncoVista Innovative Therapies) Additional Paid-In Capital : $20.22 Mil(As of Sep. 2015)

View and export this data going back to 2005. Start your Free Trial

What is OncoVista Innovative Therapies Additional Paid-In Capital?

OncoVista Innovative Therapies's quarterly additional paid-in capital stayed the same from Mar. 2015 ($20.22 Mil) to Jun. 2015 ($20.22 Mil) and stayed the same from Jun. 2015 ($20.22 Mil) to Sep. 2015 ($20.22 Mil).

OncoVista Innovative Therapies's annual additional paid-in capital increased from Dec. 2012 ($20.21 Mil) to Dec. 2013 ($20.22 Mil) but then stayed the same from Dec. 2013 ($20.22 Mil) to Dec. 2014 ($20.22 Mil).

OncoVista Innovative Therapies Additional Paid-In Capital Historical Data

The historical data trend for OncoVista Innovative Therapies's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoVista Innovative Therapies Additional Paid-In Capital Chart

OncoVista Innovative Therapies Annual Data

Trend

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Additional Paid-In Capital

Get a 7-Day Free Trial

19.89

20.13

20.21

20.22

OncoVista Innovative Therapies Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Additional Paid-In Capital	Get a 7-Day Free Trial															20.22	20.22	20.22	20.22	20.22

OncoVista Innovative Therapies Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

OncoVista Innovative Therapies Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of OncoVista Innovative Therapies's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoVista Innovative Therapies (OncoVista Innovative Therapies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoVista Innovative Therapies Inc (OTCPK:OVIT) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245

Website

http://www.oncovista.com

OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.

Executives

Alexander Ruckdaeschel	director	123 EAST 83RD STREET, APT 3-B, NEW YORK NY 10028
Paul A Mieyal	director	C/O WEXFORD CAPITAL LP, 411 WEST PUTNAM AVE, SUITE 125, GREENWICH CT 06830
Charles E Davidson	10 percent owner	C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602, WEST PALM BEACH FL 33401
Wexford Capital Lp	10 percent owner	777 WEST PUTNAM AVENUE, 1ST FLOOR, GREENWICH CT 06830
Joseph Jacobs	10 percent owner	C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602 EAST, WEST PALM BEACH FL 33401
Wexford Spectrum Trading Ltd	10 percent owner	411 WEST PUTNAM AVENUE, SUITE 125, GREENWICH CT 06830

OncoVista Innovative Therapies (OncoVista Innovative Therapies) Headlines

No Headlines